Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Internal Medicine Journal|February 12, 2020
A nationwide survey on therapeutic drug monitoring of anti-tumour necrosis factor agents for inflammatory bowel diseasePepijn W A Thomas, Paul K L Chin, Murray L Barclay
Personalized Medicine|May 23, 2018
Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel diseaseRebecca L Roberts, Richard B Gearry, Martin A Kennedy, et al.
Diseases of the Colon and Rectum|June 19, 2012
The spectrum of perianal Crohn's disease in a population-based cohortTim W Eglinton, Murray L Barclay, Richard B Gearry, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprineSharon J Gardiner, Richard B Gearry, Murray L Barclay, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|November 6, 2004
Rapid detection of common CARD15 variants in patients with inflammatory bowel diseaseRebecca L Roberts, Richard B Gearry, Murray L Barclay, et al.
Pharmacogenetics|November 27, 2004
Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprineRichard B Gearry, Rebecca L Roberts, Murray L Barclay, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 18, 2004
A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutationsRebecca L Roberts, Murray L Barclay, Richard B Gearry, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic modelsVijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
The American Journal of Gastroenterology|December 18, 2008
Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotypeKelly M Tarrant, Murray L Barclay, Christopher M A Frampton, et al.
Internal Medicine Journal|December 13, 2022
Changes in inpatient medicine prescribing during COVID-19 lockdownMillie Y Wang, Murray L Barclay, Paul K L Chin, et al.
Pageof 10